DIA and the Cardiac Safety Research Consortium (CSRC) have announced plans to collaborate on the creation of the Cardiac Safety Education Collaborative (CSEC). Both organizations share common interests in the safety of development of new therapeutics, and have worked together on a number of collaborative programs in the past. This partnership will bring together key individuals and thought leaders to address the critical aspect of cardiac safety in the drug development process.

“This partnership will leverage the complementary capabilities of DIA and CSRC in a synergistic manner to provide thought leadership and educational offerings to our broad base of stakeholders,” stated Barbara Lopez Kunz, DIA global chief executive.

The CSEC plans to advance broad stakeholder dialogue on issues related to cardiac safety. Cardiac safety concerns are one of the most significant barriers to new medical product development, and one of the most challenging areas facing regulatory science. Dr. Mitchell Krucoff, Professor of Medicine, Duke University School of Medicine and co-director of the CSRC, stated, “The DIA-CSRC collaboration through CSEC will help focus current dialogue on the cardiac safety area across a very broad base of interested stakeholders, from patients and doctors to manufacturers and regulators. Perhaps even more novel and exciting, the “signature” of CSEC programs will be to use didactic programs and Think Tanks to develop partnered projects demonstrating pragmatic solutions to these barriers.”